People receiving GLP-1 RA were generally older, more often female, and had a greater prevalence of endocrine, metabolic and gastrointestinal disorders
Mol Neurobiol 111 Gellera C, Meoni C, Castellotti B, Zappacosta B, Girotti F, Taroni F et al (1996) Errors in Huntington disease diagnostic test caused by trinucleotide deletion in the IT15 gene
No, GLP-1 receptor agonists are not licensed for rheumatoid arthritis in the UK
Regulation of dendritic spine morphology by the Rho family of small GTPases: antagonistic roles of Rac and Rho
In justified circumstances (in which the benefits outweigh the risks), nicotinic acid may be considered in order to reduce residual risk in patients with high Lp(a) concentration if other agents (i.e., PCSK9 inhibitors or inclisiran) are not available